Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Vallon Pharmaceuticals, Inc. (VLON) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Vallon Pharmaceuticals, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1824293.
Total stock buying since 2021: $104,969.
Total stock sales since 2021: $0.
Total stock option exercises since 2021: $0.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2021 | 24,750 | $104,969 | 0 | $0 | 0 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2021-06 | 6,250 | $25,174 | 0 | $0 | 0 | $0 |
| 2021-05 | 17,500 | $71,795 | 0 | $0 | 0 | $0 |
| 2021-02 | 1,000 | $8,000 | 0 | $0 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2021-06-04 | Kelly Leanne M. (Chief Financial Officer) | Buy | 1,508 | 4.08 | 6,152 |
| 2021-06-03 | Kelly Leanne M. (Chief Financial Officer) | Buy | 1,085 | 4.05 | 4,394 |
| 2021-06-02 | Kelly Leanne M. (Chief Financial Officer) | Buy | 3,657 | 4.00 | 14,628 |
| 2021-05-26 | Payne Joseph E | Buy | 6,800 | 4.50 | 30,600 |
| 2021-05-25 | Payne Joseph E | Buy | 10,700 | 3.85 | 41,195 |
| 2021-02-12 | Baker David Charles (Chief Executive Officer) | Buy | 1,000 | 8.00 | 8,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of VLON listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Vallon Pharmaceuticals, Inc. (symbol VLON, CIK number 1824293) see the Securities and Exchange Commission (SEC) website.